Jongmin Park1, Chang Won Won2, Leorey N Saligan3, Youn-Jung Kim4, Yoonju Kim4, Nada Lukkahatai5. 1. College of Nursing, 34996Pusan National University, Gyeongsangnam-do, Republic of Korea. 2. Elderly Frailty Research Center, Department of Family Medicine, College of Medicine, 26723Kyung Hee University, Seoul, Republic of Korea. 3. National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA. 4. College of Nursing Science, 26723Kyung Hee University, Seoul, Republic of Korea. 5. School of Nursing, 1466Johns Hopkins University, Baltimore, MD, USA.
Abstract
BACKGROUND: Epigenetic age acceleration has been studied as a promising biomarker of age-related conditions, including cognitive aging. This pilot study aims to explore potential cognitive aging-related biomarkers by investigating the relationship of epigenetic age acceleration and cognitive function and by examining the epigenetic age acceleration differences between successful cognitive aging (SCA) and normal cognitive aging (NCA) among Korean community-dwelling older adults (CDOAs). METHODS: We used data and blood samples of Korean CDOAs from the Korean Frailty and Aging Cohort Study. The participants were classified into two groups, SCA (above the 50th percentile in all domains of cognitive function) and NCA. The genome-wide DNA methylation profiling array using Illumina Infinium MethylationEPIC BeadChip was used to calculate the following: the DNA methylation age, universal epigenetic age acceleration, intrinsic epigenetic age acceleration (IEAA), and extrinsic epigenetic age acceleration (EEAA). We also used Pearson correlation analysis and independent t-tests to analyze the data. RESULTS: Universal age acceleration correlated with the Frontal Assessment Battery test results (r = -0.42, p = 0.025); the EEAA correlated with the Word List Recognition test results (r = -0.41, p = 0.027). There was a significant difference between SCA and NCA groups in IEAA (p = 0.041, Cohen's d = 0.82) and EEAA (p = 0.042, Cohen's d = 0.78). CONCLUSIONS: Epigenetic age acceleration can be used as a biomarker for early detection of cognitive decline in Korean community-dwelling older adults. Large longitudinal studies are warranted.
BACKGROUND: Epigenetic age acceleration has been studied as a promising biomarker of age-related conditions, including cognitive aging. This pilot study aims to explore potential cognitive aging-related biomarkers by investigating the relationship of epigenetic age acceleration and cognitive function and by examining the epigenetic age acceleration differences between successful cognitive aging (SCA) and normal cognitive aging (NCA) among Korean community-dwelling older adults (CDOAs). METHODS: We used data and blood samples of Korean CDOAs from the Korean Frailty and Aging Cohort Study. The participants were classified into two groups, SCA (above the 50th percentile in all domains of cognitive function) and NCA. The genome-wide DNA methylation profiling array using Illumina Infinium MethylationEPIC BeadChip was used to calculate the following: the DNA methylation age, universal epigenetic age acceleration, intrinsic epigenetic age acceleration (IEAA), and extrinsic epigenetic age acceleration (EEAA). We also used Pearson correlation analysis and independent t-tests to analyze the data. RESULTS: Universal age acceleration correlated with the Frontal Assessment Battery test results (r = -0.42, p = 0.025); the EEAA correlated with the Word List Recognition test results (r = -0.41, p = 0.027). There was a significant difference between SCA and NCA groups in IEAA (p = 0.041, Cohen's d = 0.82) and EEAA (p = 0.042, Cohen's d = 0.78). CONCLUSIONS: Epigenetic age acceleration can be used as a biomarker for early detection of cognitive decline in Korean community-dwelling older adults. Large longitudinal studies are warranted.
Entities:
Keywords:
DNA methylation; biomarkers; cognitive function; epigenomics; successful aging
Authors: Pierre-Antoine Dugué; Julie K Bassett; JiHoon E Joo; Chol-Hee Jung; Ee Ming Wong; Margarita Moreno-Betancur; Daniel Schmidt; Enes Makalic; Shuai Li; Gianluca Severi; Allison M Hodge; Daniel D Buchanan; Dallas R English; John L Hopper; Melissa C Southey; Graham G Giles; Roger L Milne Journal: Int J Cancer Date: 2017-12-18 Impact factor: 7.396
Authors: Darren M Lipnicki; Perminder S Sachdev; John Crawford; Simone Reppermund; Nicole A Kochan; Julian N Trollor; Brian Draper; Melissa J Slavin; Kristan Kang; Ora Lux; Karen A Mather; Henry Brodaty Journal: PLoS One Date: 2013-06-14 Impact factor: 3.240
Authors: Hyo Jung Choi; Dong Young Lee; Eun Hyun Seo; Min Kyung Jo; Bo Kyung Sohn; Young Min Choe; Min Soo Byun; Jee Wook Kim; Shin Gyeom Kim; Jong Choul Yoon; Jin Hyeong Jhoo; Ki Woong Kim; Jong Inn Woo Journal: Psychiatry Investig Date: 2013-10-16 Impact factor: 2.505